Connection

John Gnann to Herpesvirus 3, Human

Back to Details
This is a "connection" page, showing publications John Gnann has written about Herpesvirus 3, Human.
John Gnann
Connection Strength
0.359
Herpesvirus 3, Human
  1. Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine. J Infect Dis. 2013 Nov 01; 208(9):1386-90.
    View in: PubMed
    Score: 0.112
  2. Varicella-zoster virus: Prevention through vaccination. Clin Obstet Gynecol. 2012 Jun; 55(2):560-70.
    View in: PubMed
    Score: 0.103
  3. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005 Jun 02; 352(22):2271-84.
    View in: PubMed
    Score: 0.064
  4. Herpes zoster: focus on treatment in older adults. Antiviral Res. 1999 Dec 31; 44(3):145-54.
    View in: PubMed
    Score: 0.044
  5. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008 Mar 01; 197 Suppl 2:S207-15.
    View in: PubMed
    Score: 0.019
  6. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007 Jan 01; 44 Suppl 1:S1-26.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.